Senior Financial Analyst

Flagship Pioneering

Flagship Pioneering

501-1,000 employees

Originates biotech ventures for health and sustainability

Venture Capital


Cambridge, MA, USA

Required Skills
  • Motivated, well organized, and goal-oriented collaborator
  • Adaptive person and problem solver
  • Experience building relationships with all stakeholders
  • Strong analytical, excellent written and verbal communication skills
  • Advanced Microsoft Excel skills, and experience with ERP and financial planning & budgeting software required
  • Experience with data manipulation and visualization tools is a plus (Alteryx, Tableau and Microsoft Power BI)
  • Specific business partnering experience with Global IT and/or Real Estate operations is a plus
  • A minimum 3-5 years’ experience in an FP&A role/Finance operations role, preferably in the biotech/pharmaceutical industry
  • Bachelor’s degree in accounting or finance
  • Strong knowledge of accounting and finance operations required
  • MBA or CPA preferred
  • Review and track PO/Contract requests for assigned departments
  • Lease review and accounting
  • Provide detailed variance analysis of actual vs. budget/forecast
  • Collaborate with functional leaders in developing the Annual Budget, and financial forecasts, etc.
  • Prepare presentations and analyses for the leadership team
  • Contribute to FP&A monthly reporting and commentary as needed
  • Support management with ad-hoc reporting and analysis
  • Provide analytical support and modeling for business cases of new investments, as needed
  • Create financial and operational dashboards
  • Contribute to Flagship’s finance systems projects as needed
  • Other ad hoc requests and projects.

Flagship Pioneering stands out as a leader in the biotechnology industry, having originated and nurtured over 100 scientific ventures, including high-profile companies like Moderna and Indigo Agriculture. The company's culture is rooted in developing transformative products for human health and sustainability, as evidenced by their creation of platform companies like Generate Biomedicines and Tessera Therapeutics. Their competitive edge lies in their ability to explore new frontiers in genetics, as demonstrated by their recent unveiling of Quotient Therapeutics, a venture aimed at creating transformative medicines.

Company Stage


Total Funding



Cambridge, Massachusetts



Growth & Insights

6 month growth


1 year growth


2 year growth